Drug Profile
PH 46A
Alternative Names: PH46ALatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Trino Therapeutics
- Class Anti-inflammatories; Benzoates; Indans; Muscle relaxants; Small molecules
- Mechanism of Action Mast cell stabilisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ulcerative colitis
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Ulcerative-colitis(In volunteers) in United Kingdom (PO)
- 31 Aug 2014 Trino Therapeutics completes a phase I trial in Ulcerative colitis (In volunteers) in United Kingdom (ISRCTN90725219)
- 07 Feb 2014 Phase-I clinical trials in Ulcerative colitis (in volunteers) in United Kingdom (PO)